BioTime (BTX) Posts Q3 EPS of 30c

BioTime (NYSE: BTX) reported Q3 EPS of $0.30, which may not compare with the analyst estimate of ($0.14). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.23 million.

Profitability was largely due to a fain on equity method investment in Asterias at fair value.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
• Cognyte Software (CGNT) Tops Q2 EPS by 4c